Eupraxia Pharmaceuticals Inc.: Eupraxia Pharmaceuticals Reports Additional 52-week Follow-up Data from the RESOLVE Trial in Eosinophilic Esophagitis (EoE) Demonstra…

The 52-week symptom data reported for Cohort 6 patients is consistent with the long-term durability data previously reported ...

BIO-key International, Inc.: Digital Identity and Biometric Access Management Provider BIO-key Reports Q3 Results; Highlights Enhanced Post Quarter Balance Sheet to Support ...

BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced ...

Fortress Biotech, Inc.: Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Total net revenue increased 20.5% to $17.6 million for third quarter of 2025 compared to the third quarter of 2024 Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ...

BTCS, Inc.: BTCS Reports Record Revenue for the Third Quarter 2025

Revenue Increases 568% Year-over-Year and 78% Sequentially to $4.94 Million Q3 2025 Net Income Reaches $65.59 Million Driven by Ethereum Accumulation ETH Holdings Increased to 70,322, Valued at $291.5 ...

Koil Energy Solutions, Inc.: KOIL Energy Reports Third Quarter 2025 Results

Revenue of $6.4 million, 22% growth - Gross margin of 32% - Adjusted EBITDA margin of -3% due to a write-off - Successful entry into renewables - First Contracts in Brazil HOUSTON, Nov. 14, 2025 (GLOB ...

Partners Value Investments L.P. Announces Q3 2025 Interim Results

Partners Value Investments L.P. (the "Partnership", TSX: PVF.UN TSX: PVF.PR.U) announced today its financial results for the nine months ended September 30 ...

Maris-Tech Ltd.: Maris-Tech Receives Repeat Opal System Order from a Leading Israeli Defense Company

This $230,000 purchase order brings total Opal orders from the customer to approximately $1.7 million Rehovot, Israel, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) ("Maris-T ...

Zynex, Inc.: Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive ...

MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation

New clinical data show durable remissions and long-tail survivors including >2-year complete remissions in chemotherapy- and checkpoint-refractory cancersGVHD trial launching through non-dilutive fund ...

Castle Biosciences, Inc.: New Data Confirms Performance of DecisionDx-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating ...

Zimmer Biomet Holdings, Inc.: Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA Knee Robotic Technology

ROSA ® Knee with OptimiZe Offers Personalized Surgical Planning and Drives Confidence in Delivering Accurate and Reproducible Outcomes1 WARSAW, Ind., Nov. 14, 2025 /PRNewswire/ -- Zimmer ...

Zoomcar Delivers Eighth Consecutive Quarter of Positive Contribution Profit; Net Loss Narrows by 76% Year-over-Year

Delivers USD 1.2 million in contribution profit and 14% YoY EBITDA improvement in Q2 FY25-26. BENGALURU, India, Nov. 14, 2025 /PRNewswire/ -- Zoomcar Holdings Inc.